StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Protalix BioTherapeutics, Inc.
NYSE American:PLX
Sector
Location
Market Cap
USD 119.41 M
Share Price
USD 1.50
Avg Daily Volume
963,674
Change (1 day)
1.35%
Change (1 year)
33.93%
Change (YTD)
-20.21%
Protalix BioTherapeutics, Inc. Market Capitalization on July 02, 2025: USD 119.41 M
Protalix BioTherapeutics, Inc. Market Capitalization is USD 119.41 M on July 02, 2025, a 45.81% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Protalix BioTherapeutics, Inc. 52-week low Market Capitalization is USD 248.50 M on July 02, 2025, which is 108.11% above the current Market Capitalization.
-
Protalix BioTherapeutics, Inc. 52-week low Market Capitalization is USD 66.05 M on July 02, 2025, which is -44.68% below the current Market Capitalization.
-
Protalix BioTherapeutics, Inc. average Market Capitalization for the last 52 weeks is USD 130.65 M.
Competitors
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.69
603392.SS
+0.30
3.51%
Swedish Orphan Biovitrum AB (publ)
USD 29.85
SOBI.ST
-0.09
-0.31%
Ionis Pharmaceuticals, Inc.
USD 43.59
IONS
+3.65
9.14%
Shanghai Junshi Biosciences Co., Ltd.
USD 2.95
1877.HK
+0.21
7.71%
Rhythm Pharmaceuticals, Inc.
USD 66.92
RYTM
+1.48
2.26%
Hualan Biological Engineering Inc.
USD 2.19
002007.SZ
-0.01
-0.25%
Apogee Therapeutics, Inc.
USD 44.32
APGE
+0.06
0.14%
Apellis Pharmaceuticals, Inc.
USD 17.82
APLS
-0.05
-0.28%
Ligand Pharmaceuticals Incorporated
USD 113.66
LGND
+1.10
0.98%
NewAmsterdam Pharma Company N.V.
USD 18.96
NAMS
+0.74
4.06%
Adaptive Biotechnologies Corporation
USD 11.48
ADPT
+0.29
2.59%
ARS Pharmaceuticals, Inc.
USD 16.75
SPRY
+0.66
4.10%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Key Data
| Date | Market Capitalization | Share Price | Share Price | Price to Earnings Ratio (P/E) |
|---|
Competitors
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.69
603392.SS
+0.30
3.51%
Swedish Orphan Biovitrum AB (publ)
USD 29.85
SOBI.ST
-0.09
-0.31%
Ionis Pharmaceuticals, Inc.
USD 43.59
IONS
+3.65
9.14%
Shanghai Junshi Biosciences Co., Ltd.
USD 2.95
1877.HK
+0.21
7.71%
Rhythm Pharmaceuticals, Inc.
USD 66.92
RYTM
+1.48
2.26%
Hualan Biological Engineering Inc.
USD 2.19
002007.SZ
-0.01
-0.25%
Apogee Therapeutics, Inc.
USD 44.32
APGE
+0.06
0.14%
Apellis Pharmaceuticals, Inc.
USD 17.82
APLS
-0.05
-0.28%
Ligand Pharmaceuticals Incorporated
USD 113.66
LGND
+1.10
0.98%
NewAmsterdam Pharma Company N.V.
USD 18.96
NAMS
+0.74
4.06%
Adaptive Biotechnologies Corporation
USD 11.48
ADPT
+0.29
2.59%
ARS Pharmaceuticals, Inc.
USD 16.75
SPRY
+0.66
4.10%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%